Brief: Kiniksa Pharmaceuticals Announces Commercial Availability Of Arcalyst For Recurrent Pericarditis
01/04/2021 13:11
April 1 (Reuters) - Kiniksa Pharmaceuticals Ltd KNSA.O :
* KINIKSA PHARMACEUTICALS LTD - ANNOUNCES COMMERCIAL
AVAILABILITY
OF ARCALYST FOR RECURRENT PERICARDITIS
Source text for Eikon: ID:nGNX81X2ft
Further company coverage: KNSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiniksa Pharmaceuticals International
See all newsKiniksa Pharmaceuticals International, PLC reports results for the quarter ended June 30 - Earnings Summary
Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a share - Earnings Preview
Cardiovascular drugmaker Kiniksa's Q1 net income rises
Kiniksa Q4 revenue rises on ARCALYST sales